VIR ▲ +11.7% - Vir Biotechnology, Inc.
$VIR Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
14-OCT-2026 08:37 AM ET
Share this post
More filings for $VIR
VIR ▲ +5.4% - Vir Biotechnology, Inc.Oct 5, 2026VIR - Vir Biotechnology, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026$VIR SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $VIR filing history →💬 Comments
Loading comments…
Leave a comment